Transaortic septal myectomy: Techniques and pitfalls

Anthony Ralph-Edwards, Rachel D. Vanderlaan, Pietro Bajona

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Hypertrophic cardiomyopathy (HCM) is the most common congenital cardiac disease, affecting up to 1 in 200 individuals. When it causes left ventricular outflow tract (LVOT) obstruction, treatment is indicated to reduce symptoms and the risk of sudden cardiac death. Pharmacologic therapy is the first line treatment, however if it fails, surgical myectomy or percutaneous ablation of the hypertrophic myocardium are the standard therapies to eliminate subaortic obstruction. Both surgical myectomy and percutaneous ablation have been demonstrated as safe and effective treatments; however, myectomy is the gold standard with a significantly lower complication rate and more complete and longstanding reduction of LVOT obstruction.

Original languageEnglish (US)
Pages (from-to)410-415
Number of pages6
JournalAnnals of Cardiothoracic Surgery
Volume6
Issue number4
DOIs
StatePublished - Jul 1 2017

Fingerprint

Ventricular Outflow Obstruction
Hypertrophic Cardiomyopathy
Sudden Cardiac Death
Heart Diseases
Myocardium
Therapeutics

Keywords

  • Hypertrophic obstructive cardiomyopathy
  • Septal myectomy
  • Surgical techn

ASJC Scopus subject areas

  • Surgery
  • Cardiology and Cardiovascular Medicine

Cite this

Transaortic septal myectomy : Techniques and pitfalls. / Ralph-Edwards, Anthony; Vanderlaan, Rachel D.; Bajona, Pietro.

In: Annals of Cardiothoracic Surgery, Vol. 6, No. 4, 01.07.2017, p. 410-415.

Research output: Contribution to journalArticle

Ralph-Edwards, A, Vanderlaan, RD & Bajona, P 2017, 'Transaortic septal myectomy: Techniques and pitfalls', Annals of Cardiothoracic Surgery, vol. 6, no. 4, pp. 410-415. https://doi.org/10.21037/acs.2017.07.08
Ralph-Edwards, Anthony ; Vanderlaan, Rachel D. ; Bajona, Pietro. / Transaortic septal myectomy : Techniques and pitfalls. In: Annals of Cardiothoracic Surgery. 2017 ; Vol. 6, No. 4. pp. 410-415.
@article{cc1128c4c0c44692a17b1f73163b2beb,
title = "Transaortic septal myectomy: Techniques and pitfalls",
abstract = "Hypertrophic cardiomyopathy (HCM) is the most common congenital cardiac disease, affecting up to 1 in 200 individuals. When it causes left ventricular outflow tract (LVOT) obstruction, treatment is indicated to reduce symptoms and the risk of sudden cardiac death. Pharmacologic therapy is the first line treatment, however if it fails, surgical myectomy or percutaneous ablation of the hypertrophic myocardium are the standard therapies to eliminate subaortic obstruction. Both surgical myectomy and percutaneous ablation have been demonstrated as safe and effective treatments; however, myectomy is the gold standard with a significantly lower complication rate and more complete and longstanding reduction of LVOT obstruction.",
keywords = "Hypertrophic obstructive cardiomyopathy, Septal myectomy, Surgical techn",
author = "Anthony Ralph-Edwards and Vanderlaan, {Rachel D.} and Pietro Bajona",
year = "2017",
month = "7",
day = "1",
doi = "10.21037/acs.2017.07.08",
language = "English (US)",
volume = "6",
pages = "410--415",
journal = "Annals of Cardiothoracic Surgery",
issn = "2225-319X",
publisher = "AME Publishing Company",
number = "4",

}

TY - JOUR

T1 - Transaortic septal myectomy

T2 - Techniques and pitfalls

AU - Ralph-Edwards, Anthony

AU - Vanderlaan, Rachel D.

AU - Bajona, Pietro

PY - 2017/7/1

Y1 - 2017/7/1

N2 - Hypertrophic cardiomyopathy (HCM) is the most common congenital cardiac disease, affecting up to 1 in 200 individuals. When it causes left ventricular outflow tract (LVOT) obstruction, treatment is indicated to reduce symptoms and the risk of sudden cardiac death. Pharmacologic therapy is the first line treatment, however if it fails, surgical myectomy or percutaneous ablation of the hypertrophic myocardium are the standard therapies to eliminate subaortic obstruction. Both surgical myectomy and percutaneous ablation have been demonstrated as safe and effective treatments; however, myectomy is the gold standard with a significantly lower complication rate and more complete and longstanding reduction of LVOT obstruction.

AB - Hypertrophic cardiomyopathy (HCM) is the most common congenital cardiac disease, affecting up to 1 in 200 individuals. When it causes left ventricular outflow tract (LVOT) obstruction, treatment is indicated to reduce symptoms and the risk of sudden cardiac death. Pharmacologic therapy is the first line treatment, however if it fails, surgical myectomy or percutaneous ablation of the hypertrophic myocardium are the standard therapies to eliminate subaortic obstruction. Both surgical myectomy and percutaneous ablation have been demonstrated as safe and effective treatments; however, myectomy is the gold standard with a significantly lower complication rate and more complete and longstanding reduction of LVOT obstruction.

KW - Hypertrophic obstructive cardiomyopathy

KW - Septal myectomy

KW - Surgical techn

UR - http://www.scopus.com/inward/record.url?scp=85026514080&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85026514080&partnerID=8YFLogxK

U2 - 10.21037/acs.2017.07.08

DO - 10.21037/acs.2017.07.08

M3 - Article

C2 - 28944183

AN - SCOPUS:85026514080

VL - 6

SP - 410

EP - 415

JO - Annals of Cardiothoracic Surgery

JF - Annals of Cardiothoracic Surgery

SN - 2225-319X

IS - 4

ER -